Hualu Hengsheng vs Aier Eye Hospital
Two tickers, one decision framework. Instead of vibes, put both names through the same quality → valuation → thesis-breaks → timing process and let the weaker story drop.
Snapshot comparison (2026-08-28)
| 600426.SS | 300015.SZ | |
|---|---|---|
| Company | Hualu Hengsheng | Aier Eye Hospital |
| Market | 🇨🇳 China A-share | 🇨🇳 China A-share |
| Sector | Chemicals | Healthcare Svcs |
| Price | ¥20.83 | ¥8.52 |
| Signal | WAIT · +0.0% | WAIT · +0.0% |
| Total return | +33.6% | -33.6% |
Decide it with the calculator
Run both names through the free intrinsic value calculator — the one with the wider gap between price and ceiling on equal quality usually wins the slot.
Open both briefs
Run it on live data — free
Stock Chat + Screener preview · 30 monthly AI credits. Real-time scanner across US, Hong Kong, China A-shares, Korea, and India.
FAQ
Hualu Hengsheng or Aier Eye Hospital — which is the better buy?
The honest answer comes from the same workflow on both names: quality score, valuation ceiling versus today's price, and which thesis breaks worry you more. The snapshot table above gives the current dated state of each.
How are 600426.SS and 300015.SZ different?
Hualu Hengsheng trades on China A-share (Chemicals); Aier Eye Hospital trades on China A-share (Healthcare Svcs). Currency, liquidity, and disclosure regimes differ — the workflow stays identical.
Get more Balance Labs in your Google results
Add balancelabs.app as a Preferred Source on Google to see our research in Search and AI Overviews.
← All guides · Home · Data snapshot 2026-08-28 · Not investment advice.